<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Overton IM</submitter><funding>Medical Research Council</funding><funding>Wellcome Trust</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>68</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3123200</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Staphylococcus aureus is a major human pathogen and strains resistant to existing treatments continue to emerge. Development of novel treatments is therefore important. Antimicrobial peptides represent a source of potential novel antibiotics to combat resistant bacteria such as Methicillin-Resistant Staphylococcus aureus (MRSA). A promising antimicrobial peptide is ranalexin, which has potent activity against Gram-positive bacteria, and particularly S. aureus. Understanding mode of action is a key component of drug discovery and network biology approaches enable a global, integrated view of microbial physiology, including mechanisms of antibiotic killing. We developed a systems-wide functional association network approach to integrate proteome and transcriptome profiles,</pubmed_abstract><journal>BMC systems biology</journal><pubmed_title>Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus.</pubmed_title><pmcid>PMC3123200</pmcid><funding_grant_id>BBS/B/14426</funding_grant_id><funding_grant_id>086547</funding_grant_id><funding_grant_id>BBS/B/14434</funding_grant_id><pubmed_authors>Botting CH</pubmed_authors><pubmed_authors>Shirran S</pubmed_authors><pubmed_authors>Overton IM</pubmed_authors><pubmed_authors>Graham S</pubmed_authors><pubmed_authors>Coote PJ</pubmed_authors><pubmed_authors>Hinds J</pubmed_authors><pubmed_authors>Barton GJ</pubmed_authors><pubmed_authors>Gould KA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus.</name><description>&lt;h4>Background&lt;/h4>Staphylococcus aureus is a major human pathogen and strains resistant to existing treatments continue to emerge. Development of novel treatments is therefore important. Antimicrobial peptides represent a source of potential novel antibiotics to combat resistant bacteria such as Methicillin-Resistant Staphylococcus aureus (MRSA). A promising antimicrobial peptide is ranalexin, which has potent activity against Gram-positive bacteria, and particularly S. aureus. Understanding mode of action is a key component of drug discovery and network biology approaches enable a global, integrated view of microbial physiology, including mechanisms of antibiotic killing. We developed a systems-wide functional association network approach to integrate proteome and transcriptome profiles,</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 May</publication><modification>2026-04-07T15:23:29.981Z</modification><creation>2019-03-27T00:43:00Z</creation></dates><accession>S-EPMC3123200</accession><cross_references><pubmed>21569391</pubmed><doi>10.1186/1752-0509-5-68</doi></cross_references></HashMap>